Hualan Biological Engineering Inc.
002007
株式のランク
#4386
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
株価
$1.92
時価総額
$3.50B
変化（1日）
-1.39%
変化（1年）
-19.45%
国
CN
取引 Hualan Biological Engineering Inc. (002007)
カテゴリー
Healthcare
Hualan Biological Engineering Inc.（002007）のP/S比率
October 2026 時点のP/S比率 TTM: 5.36
Hualan Biological Engineering Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 5.36 です。2024 年末時点でのP/S比率は 7.02 でした。
Hualan Biological Engineering Inc. の P/S 比率の履歴（2001 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 5.36 | -11.26% |
| 2025 | 6.04 | -14.05% |
| 2024 | 7.02 | -7.05% |
| 2023 | 7.56 | -17.31% |
| 2022 | 9.14 | -23.59% |
| 2021 | 11.96 | -21.76% |
| 2020 | 15.29 | 15.15% |
| 2019 | 13.28 | 53.61% |
| 2018 | 8.64 | -21.68% |
| 2017 | 11.04 | -35.77% |
| 2016 | 17.18 | -1.12% |
| 2015 | 17.38 | 11.70% |
| 2014 | 15.56 | 4.91% |
| 2013 | 14.83 | 19.00% |
| 2012 | 12.46 | -18.28% |
| 2011 | 15.25 | -31.02% |
| 2010 | 22.10 | 35.18% |
| 2009 | 16.35 | -8.44% |
| 2008 | 17.86 | -46.00% |
| 2007 | 33.07 | 232.46% |
| 2006 | 9.95 | 356.58% |
| 2005 | 2.18 | 14.63% |
| 2004 | 1.90 | -24.46% |
| 2003 | 2.52 | -31.73% |
| 2002 | 3.69 | -27.97% |
| 2001 | 5.12 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| 10.72 | 100.04% |
US
|
|
| 41.70 | 678.04% |
US
|
|
| 4.19 | -21.81% |
AU
|
|
| 5.80 | 8.13% |
BE
|
|
| 10.44 | 94.84% |
NL
|
